Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Smolen

Showing results (41-50 of 863) with videos related to

Pageof 87
Sort By:
Best Practice & Research. Clinical Rheumatology|December 11, 2007
Mixed connective tissue disease: what is behind the curtain?Martin Aringer, Josef S Smolen
The Journal of Rheumatology. Supplement|November 19, 2002
Pharmacological management of early rheumatoid arthritis--does combination therapy improve outcomes?Maxime Dougados, Josef S Smolen
Rheumatology (Oxford, England)|December 7, 2002
The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD coursesD Aletaha, J S Smolen
Nature Reviews. Drug Discovery|May 31, 2003
Therapeutic strategies for rheumatoid arthritisJosef S Smolen, Günter Steiner
Current Opinion in Rheumatology|March 24, 2011
Monitoring rheumatoid arthritisJosef S Smolen, Daniel Aletaha
Arthritis Research & Therapy|February 24, 2009
Developments in the clinical understanding of rheumatoid arthritisJosef S Smolen, Daniel Aletaha
Rheumatic Diseases Clinics of North America|July 7, 2019
Does Triple Conventional Synthetic Disease-Modifying Antirheumatic Drug Therapy Improve upon Methotrexate as the Initial Treatment of Choice for a Rheumatoid Arthritis Patient?Daniel Aletaha, Josef S Smolen
Clinical and Experimental Rheumatology|February 19, 2004
Early arthritis. IntroductionT Pincus, J S Smolen
Clinical and Experimental Rheumatology|February 19, 2004
DMARD use in early rheumatoid arthritis. Lessons from observations in patients with established diseaseD Aletaha, J S Smolen
Clinical and Experimental Rheumatology|October 20, 2012
Gout: thoughts about a treat-to-target programmeJuergen Braun, Josef S Smolen
Pageof 87

Showing results (41-50 of 863) with videos related to

Sort By:
Pageof 87
Best Practice & Research. Clinical Rheumatology|December 11, 2007
Mixed connective tissue disease: what is behind the curtain?Martin Aringer, Josef S Smolen
The Journal of Rheumatology. Supplement|November 19, 2002
Pharmacological management of early rheumatoid arthritis--does combination therapy improve outcomes?Maxime Dougados, Josef S Smolen
Rheumatology (Oxford, England)|December 7, 2002
The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD coursesD Aletaha, J S Smolen
Nature Reviews. Drug Discovery|May 31, 2003
Therapeutic strategies for rheumatoid arthritisJosef S Smolen, Günter Steiner
Current Opinion in Rheumatology|March 24, 2011
Monitoring rheumatoid arthritisJosef S Smolen, Daniel Aletaha
Arthritis Research & Therapy|February 24, 2009
Developments in the clinical understanding of rheumatoid arthritisJosef S Smolen, Daniel Aletaha
Rheumatic Diseases Clinics of North America|July 7, 2019
Does Triple Conventional Synthetic Disease-Modifying Antirheumatic Drug Therapy Improve upon Methotrexate as the Initial Treatment of Choice for a Rheumatoid Arthritis Patient?Daniel Aletaha, Josef S Smolen
Clinical and Experimental Rheumatology|February 19, 2004
Early arthritis. IntroductionT Pincus, J S Smolen
Clinical and Experimental Rheumatology|February 19, 2004
DMARD use in early rheumatoid arthritis. Lessons from observations in patients with established diseaseD Aletaha, J S Smolen
Clinical and Experimental Rheumatology|October 20, 2012
Gout: thoughts about a treat-to-target programmeJuergen Braun, Josef S Smolen
Pageof 87